Insider Transactions in Q2 2024 at Day One Biopharmaceuticals, Inc. (DAWN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2024
|
Saira Ramasastry |
SELL
Open market or private sale
|
Direct |
10,000
-19.81%
|
$130,000
$13.19 P/Share
|
|
Jun 10
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
30,000
-2.56%
|
$360,000
$12.62 P/Share
|
|
May 16
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,873
-1.19%
|
$125,968
$16.08 P/Share
|
|
May 16
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
2,675
-1.18%
|
$42,800
$16.08 P/Share
|
|
May 16
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
2,267
-0.19%
|
$36,272
$16.08 P/Share
|
|
May 16
2024
|
Adam Dubow GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,253
-13.02%
|
$52,048
$16.08 P/Share
|
|
May 15
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,999
+1.0%
|
-
|
|
May 15
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+1.49%
|
-
|
|
May 15
2024
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,686
+0.25%
|
-
|
|
May 15
2024
|
Adam Dubow GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,399
+11.2%
|
-
|
|
May 10
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.85%
|
$160,000
$16.37 P/Share
|
|
May 03
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
9,154
-1.4%
|
$155,618
$17.85 P/Share
|
|
May 03
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
8,078
-3.58%
|
$137,326
$17.85 P/Share
|
|
May 02
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6
-0.0%
|
$102
$17.94 P/Share
|
|
May 02
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
200
-0.09%
|
$3,400
$17.9 P/Share
|
|
May 01
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
70,051
-9.7%
|
$1,190,867
$17.88 P/Share
|
|
May 01
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
52,183
-18.79%
|
$887,111
$17.89 P/Share
|
|
Apr 18
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.84%
|
$160,000
$16.02 P/Share
|